197 related articles for article (PubMed ID: 38268162)
21. Diet and biliary tract cancer risk in Shanghai, China.
Nelson SM; Gao YT; Nogueira LM; Shen MC; Wang B; Rashid A; Hsing AW; Koshiol J
PLoS One; 2017; 12(3):e0173935. PubMed ID: 28288186
[TBL] [Abstract][Full Text] [Related]
22. CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China.
Hou L; Xu J; Gao YT; Rashid A; Zheng SL; Sakoda LC; Shen MC; Wang BS; Deng J; Han TQ; Zhang BH; Meyers DA; Fraumeni JF; Hsing AW
Int J Cancer; 2006 Jun; 118(11):2847-53. PubMed ID: 16381022
[TBL] [Abstract][Full Text] [Related]
23. Malignancies of the biliary tree.
Pitt HA; Dooley WC; Yeo CJ; Cameron JL
Curr Probl Surg; 1995 Jan; 32(1):1-90. PubMed ID: 7528652
[No Abstract] [Full Text] [Related]
24. Exploring the Human Microbiome: The Potential Future Role of Next-Generation Sequencing in Disease Diagnosis and Treatment.
Malla MA; Dubey A; Kumar A; Yadav S; Hashem A; Abd Allah EF
Front Immunol; 2018; 9():2868. PubMed ID: 30666248
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study.
Wu T; Zhang Z; Liu B; Hou D; Liang Y; Zhang J; Shi P
BMC Genomics; 2013 Oct; 14():669. PubMed ID: 24083370
[TBL] [Abstract][Full Text] [Related]
26. The microbiome and hepatobiliary-pancreatic cancers.
Mima K; Nakagawa S; Sawayama H; Ishimoto T; Imai K; Iwatsuki M; Hashimoto D; Baba Y; Yamashita YI; Yoshida N; Chikamoto A; Baba H
Cancer Lett; 2017 Aug; 402():9-15. PubMed ID: 28527946
[TBL] [Abstract][Full Text] [Related]
27. The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile.
Molinero N; Ruiz L; Milani C; Gutiérrez-Díaz I; Sánchez B; Mangifesta M; Segura J; Cambero I; Campelo AB; García-Bernardo CM; Cabrera A; Rodríguez JI; González S; Rodríguez JM; Ventura M; Delgado S; Margolles A
Microbiome; 2019 Jul; 7(1):100. PubMed ID: 31272480
[TBL] [Abstract][Full Text] [Related]
28. Biliary tract cancers in Cote-d'Or (France): incidence and natural history.
Renard P; Boutron MC; Faivre J; Milan C; Bedenne L; Hillon P; Klepping C
J Epidemiol Community Health; 1987 Dec; 41(4):344-8. PubMed ID: 3455429
[TBL] [Abstract][Full Text] [Related]
29. Microbiome analysis, the immune response and transplantation in the era of next generation sequencing.
Kanangat S; Skaljic I
Hum Immunol; 2021 Nov; 82(11):883-901. PubMed ID: 34364710
[TBL] [Abstract][Full Text] [Related]
30. NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
Benson AB; D'Angelica MI; Abrams T; Abbott DE; Ahmed A; Anaya DA; Anders R; Are C; Bachini M; Binder D; Borad M; Bowlus C; Brown D; Burgoyne A; Castellanos J; Chahal P; Cloyd J; Covey AM; Glazer ES; Hawkins WG; Iyer R; Jacob R; Jennings L; Kelley RK; Kim R; Levine M; Palta M; Park JO; Raman S; Reddy S; Ronnekleiv-Kelly S; Sahai V; Singh G; Stein S; Turk A; Vauthey JN; Venook AP; Yopp A; McMillian N; Schonfeld R; Hochstetler C
J Natl Compr Canc Netw; 2023 Jul; 21(7):694-704. PubMed ID: 37433432
[TBL] [Abstract][Full Text] [Related]
31. Biliary Tract Cancer: Molecular Biology of Precursor Lesions.
Manzano-Núñez F; Prates Tiago Aguilar L; Sempoux C; Lemaigre FP
Semin Liver Dis; 2023 Nov; 43(4):472-484. PubMed ID: 37944999
[TBL] [Abstract][Full Text] [Related]
32. [Gut Microbiota and Pancreatobiliary System].
Ryu KH
Korean J Gastroenterol; 2020 May; 75(5):231-239. PubMed ID: 32448854
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part I: diagnosis-clinical staging and pathology.
Marsh Rde W; Alonzo M; Bajaj S; Baker M; Elton E; Farrell TA; Gore RM; Hall C; Nowak J; Roy H; Shaikh A; Talamonti MS
J Surg Oncol; 2012 Sep; 106(3):332-8. PubMed ID: 22488652
[TBL] [Abstract][Full Text] [Related]
34. Advances in
Shi Y; Luo J; Narbad A; Chen Q
Microorganisms; 2023 Jan; 11(1):. PubMed ID: 36677471
[TBL] [Abstract][Full Text] [Related]
35. The gut microbiome alterations in allergic and inflammatory skin diseases - an update.
Polkowska-Pruszyńska B; Gerkowicz A; Krasowska D
J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):455-464. PubMed ID: 31520544
[TBL] [Abstract][Full Text] [Related]
36. The metabolic syndrome and risk factors for biliary tract cancer: a case-control study in China.
Wu Q; He XD; Yu L; Liu W; Tao LY
Asian Pac J Cancer Prev; 2012; 13(5):1963-9. PubMed ID: 22901155
[TBL] [Abstract][Full Text] [Related]
37. Biliary Tract Cancer: Epidemiology, Radiotherapy, and Molecular Profiling.
Bridgewater JA; Goodman KA; Kalyan A; Mulcahy MF
Am Soc Clin Oncol Educ Book; 2016; 35():e194-203. PubMed ID: 27249723
[TBL] [Abstract][Full Text] [Related]
38. New challenges in cholangiocarcinoma candidates for elective surgery: harnessing the microbiome dysbiosis.
Re OL; López-López V; Balaguer-Román A; Martínez-Sánchez MA; Eshmuminov D; Llamoza-Torres CJ; Miura K; Baroja-Mazo A; Ramírez P; Robles-Campos R; Ramos-Molina B
Langenbecks Arch Surg; 2023 Mar; 408(1):134. PubMed ID: 37000331
[TBL] [Abstract][Full Text] [Related]
39. Molecular characteristics of biliary tract cancer.
Sohal DP; Shrotriya S; Abazeed M; Cruise M; Khorana A
Crit Rev Oncol Hematol; 2016 Nov; 107():111-118. PubMed ID: 27823638
[TBL] [Abstract][Full Text] [Related]
40. Targeted therapies in advanced biliary tract cancers-a narrative review.
LaPelusa M; Heumann T; Goff L; Agarwal R
Chin Clin Oncol; 2023 Apr; 12(2):14. PubMed ID: 36946186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
